Literature DB >> 24692693

Mechanisms by which synthetic 6,7-annulated-4-substituted indole compounds with anti-proliferative activity disrupt mitosis and block cytokinesis in human HL-60 tumor cells in vitro.

Jean-Pierre H Perchellet1, Elisabeth M Perchellet, Chingakham Ranjit Singh, Meghan T Monnett, Elizabeth R Studer, Paul D Thornton, Neil Brown, David Hill, Ben Neuenswander, Gerald H Lushington, Conrad Santini, Keith R Buszek.   

Abstract

BACKGROUND: Synthetic 6,7-annulated-4-substituted indole compounds, which elicit interesting antitumor effects in murine L1210 leukemia cells, were tested for their ability to inhibit human HL-60 tumor cell proliferation, disrupt mitosis and cytokinesis, and interfere with tubulin and actin polymerization in vitro.
MATERIALS AND METHODS: Various markers of metabolic activity, mitotic disruption and cytokinesis were used to assess the effectiveness of the drugs in the HL-60 tumor cell system. The ability of annulated indoles to alter the polymerizations of purified tubulin and actin were monitored in cell-free assays and were compared to the effects of drugs known to disrupt the dynamic structures of the mitotic spindle and cleavage furrow.
RESULTS: With one exception, annulated indoles inhibited the metabolic activity of HL-60 tumor cells in the low-micromolar range after two and four days in culture but these anti-proliferative effects were weaker than those of jasplakinolide, a known actin binder that blocks cytokinesis. After 24-48 h, antiproliferative concentrations of annulated indoles increased the mitotic index of HL-60 cells similarly to vincristine and stimulated the formation of many bi-nucleated cells, multi-nucleated cells and micronuclei, similarly to taxol and jasplakinolide, suggesting that these antitumor compounds might increase mitotic abnormality, induce chromosomal damage or missegregation, and block cytokinesis. Since annulated indoles mimicked the effect of vincristine on tubulin polymerization, but not that of taxol, these compounds might represent a new class of microtubule de-stabilizing agents that inhibit tubulin polymerization. Moreover, annulated indoles remarkably increased the rate and level of actin polymerization similarly to jasplakinolide, suggesting that they might also stabilize the cleavage furrow to block cytokinesis.
CONCLUSION: Although novel derivatives with different substitutions must be synthesized to elucidate structure-activity relationships, identify more potent antitumor compounds and investigate different molecular targets, annulated indoles appear to interact with both tubulin to reduce microtubule assembly and actin to block cytokinesis, thereby inducing bi- and multinucleation, resulting in genomic instability and apoptosis.

Entities:  

Keywords:  Annulated indoles; actin polymerization; cells with mitotic figures; cytokinesis; several nuclei and micronuclei; tubulin polymerization; tumor cell proliferation

Mesh:

Substances:

Year:  2014        PMID: 24692693      PMCID: PMC4618554     

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  39 in total

1.  Total synthesis of (+/-)-herbindole A, (+/-)-herbindole B, and (+/-)-cis-trikentrin A.

Authors:  Stephen K Jackson; Michael A Kerr
Journal:  J Org Chem       Date:  2007-01-26       Impact factor: 4.354

Review 2.  Control of cortical contractility during cytokinesis.

Authors:  Michael Werner; Michael Glotzer
Journal:  Biochem Soc Trans       Date:  2008-06       Impact factor: 5.407

3.  New class of antifungal agents: jasplakinolide, a cyclodepsipeptide from the marine sponge, Jaspis species.

Authors:  V R Scott; R Boehme; T R Matthews
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

4.  Pyrene actin: documentation of the validity of a sensitive assay for actin polymerization.

Authors:  J A Cooper; S B Walker; T D Pollard
Journal:  J Muscle Res Cell Motil       Date:  1983-04       Impact factor: 2.698

5.  Isolation and structure elucidation of teleocidin B-1, B-2, B-3, and B-4.

Authors:  Y Hitotsuyanagi; H Fujiki; M Suganuma; N Aimi; S Sakai; Y Endo; K Shudo; T Sugimura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1984-10       Impact factor: 1.645

6.  Excess F-actin mechanically impedes mitosis leading to cytokinesis failure in X-linked neutropenia by exceeding Aurora B kinase error correction capacity.

Authors:  Dale A Moulding; Emad Moeendarbary; Leo Valon; Julien Record; Guillaume T Charras; Adrian J Thrasher
Journal:  Blood       Date:  2012-09-12       Impact factor: 22.113

7.  Inhibition of tubulin polymerization by 5,6-dihydroindolo[2,1-alpha]isoquinoline derivatives.

Authors:  M Goldbrunner; G Loidl; T Polossek; A Mannschreck; E von Angerer
Journal:  J Med Chem       Date:  1997-10-24       Impact factor: 7.446

8.  Selective elimination of acentric double minutes from cancer cells through the extrusion of micronuclei.

Authors:  N Shimizu; T Shimura; T Tanaka
Journal:  Mutat Res       Date:  2000-03-14       Impact factor: 2.433

9.  Taxol assembles tubulin in the absence of exogenous guanosine 5'-triphosphate or microtubule-associated proteins.

Authors:  P B Schiff; S B Horwitz
Journal:  Biochemistry       Date:  1981-05-26       Impact factor: 3.162

10.  HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures.

Authors:  M Fenech; W P Chang; M Kirsch-Volders; N Holland; S Bonassi; E Zeiger
Journal:  Mutat Res       Date:  2003-01-10       Impact factor: 2.433

View more
  2 in total

1.  A Practical, Multi-gram Synthesis of (±)-Herbindole A, (±)-Herbindole B, and (±)-Herbindole C from a Common Intermediate via 6,7-Indole Aryne Cycloaddition and Pd(0)-Catalyzed Cross-Coupling Reactions.

Authors:  Nalin Chandrasoma; Sivadarshini Pathmanathan; Keith R Buszek
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

2.  Substituted Tetrahydroisoquinolines as Microtubule-destabilizing Agents in Triple Negative Human Breast Cancer Cells.

Authors:  Madhavi Gangapuram; Riccardo Jean; Elizabeth Mazzio; Ramesh Badisa; Suresh Eyunni; Carl B Goodman; Kinfe K Redda; Karam F Soliman
Journal:  Anticancer Res       Date:  2016-10       Impact factor: 2.480

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.